FREE DESIGN AUDIT
Free Design Audit Available - Click Here for Details

Blog

- Uncategorized

Non-invasive sensor measures intracranial pressure more accurately, aiding early intervention

March 13, 2025

A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of intracranial pressure (ICP) more accurately than existing non-invasive methods. This is the result of a study published in the journal npj Digital Medicine by researchers from the University of São Paulo in Brazil, the University of Cambridge in the United Kingdom, Emory University in the United States, and the company itself.

Read More »

COVID-19 discovery opens door to new treatments for chronic lung problems

March 13, 2025

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells’ ability to repair the lungs, helping explain the lingering effects of long COVID. The findings suggest a new treatment approach for long COVID as well as other conditions, both short-term and chronic, caused by respiratory infections such as the flu.

Read More »

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System

March 13, 2025

HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ — Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS).

Read More »

Vave Health Introduces World’s First Wireless, Handheld, Whole-Body Ultrasound with a Single PZT Transducer

March 13, 2025

SAN JOSE, Calif., March 13, 2025 /PRNewswire/ — Vave Health proudly announces the launch of its Universal Wireless Probe. This simple, innovative device is designed to enhance efficiency, accuracy, and diagnostics in a variety of clinical and educational settings. Its combination of linear and phased imaging technology provides high quality, full-body imaging with no ongoing subscription fees or hidden costs.

Read More »

Robotics and spinal stimulation restore movement in paralysis

March 12, 2025

Spinal cord injuries are life-altering, often leaving individuals with severe mobility impairments. While rehabilitation robotics—devices that guide movement during therapy—have improved training for those with spinal cord injuries, their effectiveness remains limited. Without active muscle engagement, robotic-assisted movement alone does not sufficiently retrain the nervous system.

Read More »

Elute Earns U.S. FDA Clearance for Its Novel Synthetic Resorbable Bone Void Filler

March 12, 2025

SALT LAKE CITY, March 12, 2025 /PRNewswire/ — For the thousands of patients in the United States requiring treatment for bone loss or defects caused by trauma or infections, Elute, Inc., a clinical stage company and emerging leader with a groundbreaking controlled and extended drug delivery platform, proudly announces U.S. Food and Drug Administration (FDA) approval of BonVie+™, a novel bone void filler implant.

Read More »